Tag archief: English Only

Moody’s Analytics uitgeroepen tot categorieleider in IFRS 9 Market Update van Chartis Research

NEW YORK–(BUSINESS WIRE)– Moody’s Analytics is erkend als categorieleider in een nieuw rapport van Chartis Research,  IFRS 9 Technology Solutions: Market Update 2017, waarin vijftien toonaangevende...

Strategic Minority Investment Company MiNA Therapeutics Enters Into Collaboration and Licensing Agreement With Boehringer Ingelheim

TOKYO–(BUSINESS WIRE)– Sosei Group Corporation (‘Sosei’; TSE Mothers Index 4565), is pleased to note that our strategic minority investment company MiNA Therapeutics (‘MiNA’) has announced...

Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases

INGELHEIM, Germany & LONDON–(BUSINESS WIRE)– Boehringer Ingelheim and MiNA Therapeutics (“MiNA”), a pioneer in RNA activation therapeutics, today announced that they have signed a collaboration...

Speedcast and SES Networks Partner in Latin America to Provide Fibre-like Connectivity

Partnership will provide hundreds of Mbps of connectivity into Peru to drive new economic growth SYDNEY & BETZDORF, Luxembourg–(BUSINESS WIRE)– Speedcast, a leader in providing...

Global Organizations Invited to Transform Customer Experiences at Axway SPARK 2017

PARIS–(BUSINESS WIRE)– Axway (Euronext: AXW.PA), a catalyst for digital transformation, is hosting an interactive virtual event on Thursday, 16 November to help organizations to adapt...

Moody’s Analytics wins Best Buy-Side Market Surveillance Tool in Waters Buy-Side Technology Awards

NEW YORK–(BUSINESS WIRE)– Moody’s Analytics has won the Best Buy-Side Market Surveillance Tool/Platform category in the annual Waters Technology Buy-Side Technology Awards. This award recognizes...

BearingPoint: Europe’s Main Car Producing Countries Lag in Electric Market Share, Global Sales Continue to Grow

BearingPoint issues its Automotive Electric Market Overview: Norway leads in total market share and China leads in total sales FRANKFURT, Germany–(BUSINESS WIRE)– The power of...

SES Networks First to Achieve MEF CE 2.0 Services Certification Over Satellite

MEF-certified Ethernet services from SES Networks provide customers with standardised service options that are easily and seamlessly integrated into current operations LUXEMBOURG–(BUSINESS WIRE)– SES Networks...

Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase 2 Data Published in The Lancet Infectious Diseases

OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TSE: 4502), (“Takeda”) today announced that data from an 18-month interim analysis of the ongoing Phase 2 DEN-204...

IFF Reports Third Quarter 2017 Results

Achieved strong financial performance in Q3; Reconfirms full year currency neutral guidance NEW YORK–(BUSINESS WIRE)– International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF),...

Efficacy and safety maintained in patients who switched from Humira® to biosimilar Cyltezo®

INGELHEIM, Germany–(BUSINESS WIRE)– Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA, a pivotal Phase III clinical trial comparing Cyltezo® (adalimumab-adbm) and reference product Humira®*. The...

Reply’s Student Tech Clash, is Starting Now: the Challenge is “the Future of Payments”

LONDON–(BUSINESS WIRE)– Netflix has revolutionised the entertainment industry without owning any television channels. Uber has forever changed the world of public transport without owning a...

ISA TanTec Acquires a Major Stake in an Italian Tannery

VICENZA, Italy–(BUSINESS WIRE)– ISA TanTec is pleased to announce the acquisition of a major stake in Scamosceria del Brenta Srl (Scabrenta), an Italian tannery with...

Vertex Announces Presentations of Data at North American Cystic Fibrosis Conference that Demonstrate Important Progress Toward Goal of Helping All People with CF

– First presentation of previously announced early data from Phase 1 and Phase 2 studies of three different triple combination regimens – – New data...

Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Treatment in People with Cystic Fibrosis Ages 12 and Older Published in the New England Journal of Medicine

  – Tezacaftor/ivacaftor currently under review by the FDA and EMA; FDA Priority Review action date of February 28, 2018 – – Data showed significant...